1-4 of 4
Gary Binder, MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Treatment Initiation in Myelodysplastic Syndromes (MDS) Produces Higher Rate of and Earlier Transfusion Independence

Christopher R. Cogle, MD, Sheila R. Reddy, PhD RPh, Eunice Chang, PhD, Elya Papoyan, MPH, Michael S. Broder, MD MSHS, Michael McGuire, PharmD, Gary Binder, MBA
Journal: Blood
Blood (2016) 128 (22): 395.
https://doi.org/10.1182/blood.V128.22.395.395
Published: 2016
Journal Articles

Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)

Aaron T. Gerds, MD MS, Shaloo Gupta, MS, Gary Binder, MBA, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Stephanie Hawthorne, PhD, Kristen King-Concialdi, BS, Michael McGuire, PharmD
Journal: Blood
Blood (2016) 128 (22): 3541.
https://doi.org/10.1182/blood.V128.22.3541.3541
Published: 2016
Journal Articles

Cost-Effectiveness Of Lenalidomide and Bortezomib In Patients With Previously Untreated Multiple Myeloma (MM)

Gerry Oster, PhD, Ariel Berger, MPH, Rebecca Bornheimer, BA, Gary Binder, MBA, Yasir Nagarwala, MD
Journal: Blood
Blood (2013) 122 (21): 5604.
https://doi.org/10.1182/blood.V122.21.5604.5604
Published: 2013
Journal Articles

Relationship Between Lenalidomide Dose Modification and Duration Of Treatment In Newly Diagnosed Multiple Myeloma Patients

Kathy Lang, PhD, Gary Binder, MBA, Iris Lin, PhD, Dejan Milentijevic, PhD, Huan Huang, PhD, Yasir Nagarwala, MD, William N. Harwin, MD
Journal: Blood
Blood (2013) 122 (21): 2944.
https://doi.org/10.1182/blood.V122.21.2944.2944
Published: 2013